An extended analysis of the ODYSSEY OUTCOMES trial has confirmed alirocumab, a PCSK9 inhibitor that hit the medical market in 2015, reduces a patient’s total risk of nonfatal and fatal cardiovascular events after an acute coronary syndrome (ACS).
A study of Native Americans who experienced ischemic stroke showed they carried a high burden of risk factors, nearly all of which grew in prevalence from 2000 to 2016.
Anthem, the nation’s second-largest health insurer, is planning to push up the launch date of its new pharmacy benefit manager (PBM) business, the company announced during its end-of-year earnings report.
GIBLIB, an Los Angeles-based streaming media platform, has launched a virtual reality (VR) app that provides an immersive operating room (OR) experience to medical students and physicians.
A projected increase in extreme weather driven by climate change could have a lasting effect on expectant mothers and their children, according to a study that recently linked maternal heat exposure to an elevated risk of congenital heart defects (CHDs) in the U.S.
As AI systems leave laboratories and are implemented in real world settings, bias will continue to be “an increasingly widespread problem.” So how can it be solved?
